StonvexLoading…
StonvexCore line items from CPS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $711.39M | $686.36M | $2.74B | $2.07B | $1.37B |
Operating Income | Not available | $24.06M | $86.60M | $86.01M | $59.54M |
Net Income | Not available | $-33.30M | $-4.17M | $-7.49M | $151.00K |
EPS (Diluted) | $0.61 | $-1.85 | $-0.23 | $-0.42 | $0.01 |
Total Assets | Not available | $1.85B | $1.83B | $1.86B | $1.82B |
Total Liabilities | Not available | $1.98B | $1.92B | $1.97B | $1.93B |
Cash & Equivalents | Not available | $118.49M | $191.70M | $147.62M | $121.62M |
Free Cash Flow OCF − CapEx | Not available | $-93.19M | $16.25M | $-28.31M | $-55.75M |
Shares Outstanding | Not available | 17.76M | 17.64M | 17.64M | 17.63M |